Nasopharyngeal carcinoma: molecular biomarker discovery and progress.
about
An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinomaHyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cellsOmics-based identification of biomarkers for nasopharyngeal carcinomaNasopharyngeal carcinoma in Indonesia: epidemiology, incidence, signs, and symptoms at presentationEpstein-Barr virus-encoded latent membrane protein 1 impairs G2 checkpoint in human nasopharyngeal epithelial cells through defective Chk1 activationMeta-analysis of nasopharyngeal carcinoma microarray data explores mechanism of EBV-regulated neoplastic transformationAnti-tumor effect of oncolytic herpes simplex virus G47delta on human nasopharyngeal carcinoma.Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinomaIntegration of biomarkers including molecular targeted therapies in head and neck cancer.Correlation of five secretory proteins with the nasopharyngeal carcinoma metastasis and the clinical applications.Interleukins, laminin and Epstein - Barr virus latent membrane protein 1 (EBV LMP1) promote metastatic phenotype in nasopharyngeal carcinomaSerum biomarkers which correlate with failure to respond to immunotherapy and tumor progression in a murine colorectal cancer model.Notch1 signaling is activated in cells expressing embryonic stem cell proteins in human primary nasopharyngeal carcinoma.Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma.Increased expression of flotillin-2 protein as a novel biomarker for lymph node metastasis in nasopharyngeal carcinoma.Potential tumor suppressor NESG1 as an unfavorable prognosis factor in nasopharyngeal carcinoma.Activation of Akt/mTOR pathway is associated with poor prognosis of nasopharyngeal carcinoma.Molecular prognostic prediction for locally advanced nasopharyngeal carcinoma by support vector machine integrated approachPreparation of human scFv antibody against nasopharyngeal carcinoma and identification of its specificity.Increased expression of IRS-1 is associated with lymph node metastasis in nasopharyngeal carcinoma.Comparative serum proteomic analysis involving liver organ-specific metastasis-associated proteins of nasopharyngeal carcinoma.Identifying cancer driver genes in tumor genome sequencing studies.Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case-control study and meta-analysisHigh expression of ubiquitin-conjugating enzyme 2C (UBE2C) correlates with nasopharyngeal carcinoma progression.Generation and characterization of a novel recombinant antibody against LMP1-TES1 of Epstein-Barr virus isolated by phage display.Molecular markers to assess short-term disease local recurrence in nasopharyngeal carcinoma.Phosphorylated Mnk1 and eIF4E are associated with lymph node metastasis and poor prognosis of nasopharyngeal carcinoma.High expression of Talin-1 is associated with poor prognosis in patients with nasopharyngeal carcinoma.The important role of the receptor for activated C kinase 1 (RACK1) in nasopharyngeal carcinoma progression.Up-regulation of serum miR-744 predicts poor prognosis in patients with nasopharyngeal carcinomaNiflumic acid exhibits anti-tumor activity in nasopharyngeal carcinoma cells through affecting the expression of ERK1/2 and the activity of MMP2 and MMP9Nuclear overexpression of metastasis-associated protein 1 correlates significantly with poor survival in nasopharyngeal carcinomaTargeting annexin A2 reduces tumorigenesis and therapeutic resistance of nasopharyngeal carcinoma.The progress on genetic analysis of nasopharyngeal carcinoma.The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis.Association of the p53 or GSTM1 polymorphism with the risk of nasopharyngeal carcinoma: A meta-analysisAnticancer effects of 3,3'-diindolylmethane are associated with G1 arrest and mitochondria-dependent apoptosis in human nasopharyngeal carcinoma cellsHyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells.Oncoproteomics: current trends and future perspectives.Scavenger receptor B1 is a potential biomarker of human nasopharyngeal carcinoma and its growth is inhibited by HDL-mimetic nanoparticles.
P2860
Q21202158-46559A62-4AA1-4113-A4B2-BA591390F8A3Q24319922-6C67914B-02CF-4A2D-BD8B-94A8A5EE7563Q28082480-7CB5617B-3C9A-4DFA-B06F-914B35583646Q28680671-5D333843-7281-4D4C-8FFC-DAB12CF063E7Q28728022-62F39450-51F4-44DF-8D29-A4DAEFD796D5Q30844939-BCFD8BD4-17E1-4722-868B-0CC33B1EEFF7Q33579396-C96D1240-7585-4600-8EE5-3E4DAAD6CAEAQ33599264-15C891F7-7B39-4A1C-AB28-154505C07B5EQ33674090-E3C85151-CFC4-4351-B370-53DADC3E462BQ33710134-CDCA3595-9CE3-4466-A91C-65A7F62F1ADAQ33724843-D3D2FB90-7B32-40C1-88DF-46C0A0597C85Q33764534-74D57585-3A42-478E-8309-9B20C45EC14DQ33829691-7FE4D53F-7DF7-41E2-ACC8-D6339AD8F2E3Q33864140-467B7575-2375-4088-8321-0498C86A2819Q33889850-773ABAC6-CD42-4200-8225-BBF7BBCD6ADCQ34091097-17BBC062-DE24-483F-80A0-BBCBEC263D0BQ34105105-FB250387-E04B-4D0A-A64B-DB255D1DB7E1Q34199695-1F9D5818-190F-483E-84B6-0792AC4244C5Q34230754-9821BBD8-826D-4C95-9028-7190C7342BA5Q34371614-8B4D16FC-8CF0-4E86-9920-9BB71F31D23DQ34411959-22485F05-F998-43D8-8473-8DCE1A26BDEAQ34480097-6DB31715-7994-49AB-8F0F-2DF6E2088CBAQ34542602-B4A9E0F5-BA4B-47F0-9B4E-4EE4F365F5BDQ34669229-EAB127F2-3E5A-49A5-9366-F4A84F8B40D0Q34682093-7D871F49-D5F6-44D8-BAF0-391D86C0AE75Q35072994-C7D2A476-CC20-477B-B9F5-77489EB7D718Q35097767-6C814C1E-EEB8-46D5-99DD-8BD918F1DD89Q35583857-85231463-25C0-4BA2-A303-A41E358FB90BQ36015166-EE30E8A2-9597-4ECA-9E8C-AF2A9EEB7BF6Q36183019-26CD35EE-8042-4856-BFA9-22FC78CBC026Q36262238-1418ED6E-E85B-47F9-9795-7BCA433C7575Q36338573-24536548-90B7-4858-8FD2-D1567087214EQ36413665-C58D7EC7-DBE3-409B-A00F-0E8B79932596Q36445020-BD691FA0-FA82-4492-A21B-6C327768C8E1Q36513706-CAEBE967-34A0-4996-8A10-C80AF0052509Q36524063-A6B463F9-F0DF-4E04-9864-8B2E67DF99C8Q36611614-FD4D8137-7A00-4999-87E5-98F812955636Q36719279-BF7D5576-3C82-4EFB-9C0E-B724498FFAADQ36841889-4426A2ED-3FDF-4693-8580-6944F23ED061Q36997612-A142D187-F867-454B-9820-F42BA8A61BCC
P2860
Nasopharyngeal carcinoma: molecular biomarker discovery and progress.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Nasopharyngeal carcinoma: molecular biomarker discovery and progress.
@ast
Nasopharyngeal carcinoma: molecular biomarker discovery and progress.
@en
type
label
Nasopharyngeal carcinoma: molecular biomarker discovery and progress.
@ast
Nasopharyngeal carcinoma: molecular biomarker discovery and progress.
@en
prefLabel
Nasopharyngeal carcinoma: molecular biomarker discovery and progress.
@ast
Nasopharyngeal carcinoma: molecular biomarker discovery and progress.
@en
P2860
P921
P356
P1433
P1476
Nasopharyngeal carcinoma: molecular biomarker discovery and progress.
@en
P2093
William Chi-Shing Cho
P2860
P2888
P356
10.1186/1476-4598-6-1
P5008
P577
2007-01-02T00:00:00Z
P5875
P6179
1052208741